ÂÜÀòÂÒÂ×

Christine Granfield has over 30 years of work experience in regulatory affairs and quality. Christine is currently the Vice President of Regulatory Affairs & Quality at Leap Therapeutics, a role they have held since August 2020. Prior to this, they worked as an Independent Consultant at Granfield Associates, LLC from October 2016 to August 2020. From August 2011 to September 2016, Christine served as the Senior Director of Regulatory Affairs for Companion Diagnostics at Novartis Oncology. Before that, they held the position of Senior Director of Regulatory Affairs at Genzyme from October 1998 to June 2011. Christine began their career at the FDA as a Biomedical Engineer in the Office of Device Evaluation, CDRH, from 1990 to 1992. Christine then worked as a Regulatory Engineer at B. Braun Medical from 1992 to 1994. Finally, they served as a Project Manager of Regulatory Affairs at Boston Scientific from 1994 to 1998.

Christine Granfield received a Bachelor of Science in Engineering in Biomedical Engineering from The Catholic University of America, from 1986 to 1990.